YGION Biomedical

ygion.bio

YGION Biomedical is an innovative biotechnology company focused on developing individualized neoantigen-based cancer immunotherapies. Founded in 2022, the company aims to create personalized cancer vaccines that maximize treatment effectiveness while minimizing side effects. By leveraging advanced technology platforms and expertise in immuno-oncology, YGION seeks to empower patients' immune systems to target and eradicate tumor cells. Their unique YGNITE™ technology platform is designed to identify and deliver relevant peptide neoantigens, leading to safe and potent immune responses. With a commitment to improving patient outcomes, YGION is positioned to make significant strides in the field of cancer treatment.